|
|
|
|
LEADER |
02828nam a2200289Ia 4500 |
001 |
10-3390-jcm11061596 |
008 |
220420s2022 CNT 000 0 und d |
020 |
|
|
|a 20770383 (ISSN)
|
245 |
1 |
0 |
|a Increased Prognostic Yield by Combined Assessment of Non-Contrast Computed Tomography Markers of Antithrombotic-Related Spontaneous Intracerebral Hemorrhage Expansion
|
260 |
|
0 |
|b MDPI
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.3390/jcm11061596
|
520 |
3 |
|
|a Background and aims: The utility of proposed non-contrast computed tomography (NCCT) markers for the prediction of hematoma expansion in patients with antithrombotic-related spontaneous intracerebral hemorrhage (ICH) is limited. Additionally, there is significant overlap between different suggested ICH shape and density markers. Methods: We assessed the prognostic yield for hematoma expansion of a combined score incorporating features of ICH shape irregularity (satellite sign and/or Barras score ≥ 3), heterogeneous ICH density (swirl sign and/or Barras score ≥ 3) on baseline NCCT and timing from ICH onset to NCCT. Results: We evaluated data from 79 patients with antithrombotic-related spontaneous ICH (32% with hematoma expansion). Swirl (84% vs. 39%) and satellite signs (20% vs. 7%) on baseline NCCT were significantly more prevalent (p < 0.001) in patients with hematoma expansion. Patients with hematoma expansion had more irregular and heterogeneous bleeds on baseline NCCT scans, as quantified by higher (p < 0.001) Barras shape (4 (4–5) vs. 3 (2–4)) and density scores (4 (3–5) vs. 2 (1–3)), respectively. The overall diagnostic yield of the combined score (area under the curve: 0.86, 95%CI: 0.78–0.94) significantly outperformed (p < 0.001) the diagnostic yield of each individual marker. Scores of 4 or 5 in the combined score were associated with a sensitivity of 60.0%, specificity of 90.7%, overall diagnostic accuracy of 81.0%, positive likelihood ratio (LR) of 6.48, negative LR of 0.44, positive predictive value (PV) of 0.76 and negative PV of 0.83. Conclusion: Combined NCCT marker assessment seems to increase the prognostic accuracy for hematoma expansion in antithrombotic-related spontaneous ICH patients. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
|
650 |
0 |
4 |
|a Hematoma expansion
|
650 |
0 |
4 |
|a Intracerebral hemorrhage
|
650 |
0 |
4 |
|a Predictive score
|
700 |
1 |
0 |
|a Al-Zahrani, S.
|e author
|
700 |
1 |
0 |
|a Beshara, S.
|e author
|
700 |
1 |
0 |
|a Charidimou, A.
|e author
|
700 |
1 |
0 |
|a Dowlatshahi, D.
|e author
|
700 |
1 |
0 |
|a Goldstein, J.N.
|e author
|
700 |
1 |
0 |
|a Gupta, H.
|e author
|
700 |
1 |
0 |
|a Katsanos, A.H.
|e author
|
700 |
1 |
0 |
|a Morotti, A.
|e author
|
700 |
1 |
0 |
|a Patil, T.
|e author
|
700 |
1 |
0 |
|a Shoamanesh, A.
|e author
|
700 |
1 |
0 |
|a Tsivgoulis, G.
|e author
|
773 |
|
|
|t Journal of Clinical Medicine
|